Shanti Inorganics Share Price & Earnings Call Analysis
- Market cap
- ₹305 Cr
- P/E
- 30.00
- ROE
- 27.57%
- Price to sales
- 4.27
- Debt to equity
- 0.64
- 52W high / low
- ₹224 / ₹150
- EBITDA margin
- 21.62%
- Net profit margin
- 14.29%
- Promoter holding
- 56.05%
- Sales (last year)
- ₹71 Cr
Incorporated in January 2010, Shanti Inorganics Ltd. manufactures and trades sulfur-based inorganic chemicals.[1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹234 Cr | 3.0 | |
| 2 | 40%+ | Flat | ₹3,888 Cr | 48.5 | |
| 3 | 40%+ | Flat | ₹3,514 Cr | 4.3 | |
| 4 | 40%+ | Flat | ₹180 Cr | 11.9 | |
| 5 | 40%+ | Flat | ₹138 Cr | 15.1 | |
| 6 | 20–40% | Up 2%+ | ₹1.70L Cr | 85.4 |
Sign up free to see every company in the sector ranking and track Shanti Inorganics.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of Shanti Inorganics
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Shareholder Pattern
Shanti Inorganics
Shareholding breakup across reporting periods.
| Sep 2026 | |
|---|---|
| Promoters + | 56.05% |
| FIIs + | 6.36% |
| DIIs + | 9.42% |
| Public + | 28.17% |
| No. of Shareholders | 875 |
Financials of Shanti Inorganics
Quarterly Results
Quarter-by-quarter operating performance
| Sales + |
| Expenses + |
| Operating Profit |
| OPM % |
| Other Income + |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit + |
| EPS in Rs |
Financials of Shanti Inorganics
Profit & Loss
Annual income statement trend
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales + | 45 | 57 | 71 |
| Expenses + | 36 | 45 | 56 |
| Operating Profit | 9 | 12 | 15 |
| OPM % | 19% | 21% | 22% |
| Other Income + | 0 | 1 | 2 |
| Interest | 1 | 2 | 1 |
| Depreciation | 1 | 1 | 2 |
| Profit before tax | 7 | 11 | 14 |
| Tax % | 25% | 26% | 26% |
| Net Profit + | 5 | 8 | 10 |
| EPS in Rs | 80.50 | 125.63 | 8.84 |
| Dividend Payout % | -0% | -0% | -0% |
Financials of Shanti Inorganics
Balance Sheet
Capital structure and asset base
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 0.64 | 0.64 | 12 |
| Reserves | 17 | 25 | 37 |
| Borrowings + | 24 | 25 | 31 |
| Other Liabilities + | 11 | 15 | 18 |
| Total Liabilities | 53 | 66 | 97 |
| Fixed Assets + | 7 | 37 | 40 |
| CWIP | 18 | 5 | 12 |
| Investments | 1 | 1 | 1 |
| Other Assets + | 27 | 23 | 45 |
| Total Assets | 53 | 66 | 97 |
Financials of Shanti Inorganics
Cash Flows
Operating, investing and financing cash movement
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from Operating Activity + | 3 | 16 | 6 |
| Cash from Investing Activity + | -19 | -16 | -22 |
| Cash from Financing Activity + | 17 | -1 | 16 |
| Net Cash Flow | 1 | -1 | 0 |
| Free Cash Flow | -16 | -2 | -5 |
| CFO/OP | 55% | 145% | 63% |
Financials of Shanti Inorganics
Ratios
Working capital efficiency and return ratios
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 97 | 100 | 101 |
| Inventory Days | 11 | 37 | 64 |
| Days Payable | 124 | 167 | 136 |
| Cash Conversion Cycle | -17 | -29 | 30 |
| Working Capital Days | 6 | -41 | 30 |
| ROCE % | 26% | 23% |
Continue your research
Others in Chemicals & Petrochemicals this season
- J.G.Chemicals (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd
- Lords Chloro (Q2 FY27)
115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against
- Camlin Fine (Q2 FY27)
Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27
- Gujarat Fluoroch (Q2 FY27)
Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv